Preview

Veterinary Science Today

Advanced search

Isolation and study of biological properties of Bordetella bronchiseptica-specific bacteriophages

https://doi.org/10.29326/2304-196X-2022-11-3-273-279

Abstract

The paper presents results of our studies on isolation of bacteriophages active against Bordetella bronchiseptica. Three new bacteriophages were recovered from clinical material of animals with respiratory disease signs: vB_BbrS_2/200220.7.2, vB_BbrS_4/200220.7.1, vB_BbrM_5/200220.7.2. The lytic activity of isolated bacteriophages determined by the method of agar layers varied from (2.3 ± 1.4) × 108  to (9.0 ± 0.2) × 108  BOE/ml, and the lytic spectrum ranged from 61.5 to 76.9%. The bacteriophage titer stability was shown during 8-month storage of phage lysate with no preservative added. The morphology of bacteriophage negative colonies was tested in various nutrient media and analyzed based on two parameters: size and transparency. Dissociation of negative colonies into clear colonies, cloudy colonies, and clear colonies with cloudy halos was observed in the media. Plaques also varied in size from 0.6 ± 0.2 to 2.6 ± 0.1 mm. High levels of temperature stability were noted during exposure of bacteriophages to high temperatures ranging from +40 to +95 °C in 5 °C step. The study of specificity showed that the isolated bacteriophages lyse closely-related bacteria. In the course of electron microscopic testing of each bacteriophage such parameters as the average diameter of the head and the average length of the tail were determined. In accordance with the international classification of viruses by morphological characteristics the vB_BbrS_2/200220.7.2 and vB_BbrS_4/200220.7.1 phages have been assigned to the family Siphoviridae, vB_BbrM_5/200220.7.2 bacteriophage has been assigned to the family Myoviridae. The obtained results of in vitro studies have shown that the isolated bacteriophages can be prespective in veterinary use for phage therapy of Bordetella bronchiseptica-induced diseases.

About the Authors

T. A. Kochetova
Research and Production Center “MicroMir” LLC
Russian Federation

Tatiana A. Kochetova, Researcher

107031, Moscow, Nizhnii Kisel’nyi pereulok, d. 5/23, str. 1



V. V. Yuskevich
Research and Production Center “MicroMir” LLC
Russian Federation

Victoria V. Yuskevich, Candidate of Science (Biology), Head of
Bacteriological Laboratory

Moscow



G. T. Sadykova
Research and Production Center “MicroMir” LLC
Russian Federation

Gulnur T. Sadykova, Researcher

Moscow



V. M. Popova
Research andProduction Center “MicroMir” LLC
Russian Federation

Valentina M. Popova, Candidate of Science (Medicine), Deputy General Director

Moscow



References

1. Belyaeva A. S., Savinov V. A., Kapustin A. V., Laishevtcev A. I. Animal bordetellosis. Bulletin of the Kursk Agricultural Academy. 2019; 7: 111–119. eLIBRARY ID: 41253859. (in Russ.)

2. Vasiliev D. A., Vasilieva Ju. B., Mastilenko A. V., Sverkalova D. G., Semanina E. N., Borisova O. Ju., et al. Animal bordetellosis: disease and pathogen description, diagnostic method development. Ulyanovsk: USAU named after P. A. Stolypin; 2014. 206 p. (in Russ.)

3. МР 3.1.2.0072-13 Whooping cough and parapertussis diagnosis: methodical guidelines. Moscow: Federal Center for Hygiene and Epidemiology of Rospotrebnadzor; 2013. 56 p. Available at: https://files.stroyinf.ru/Data2/1/4293743/4293743262.pdf. (in Russ.)

4. Szymczak M., Grygorcewicz B., Karczewska-Golec J., Decewicz P., Pankowski J. A., Országh-Szturo H., et al. Characterization of a unique Bordetella bronchiseptica vB_BbrP_BB8 bacteriophage and its application as an antibacterial agent. Int. J. Mol. Sci. 2020; 21 (4):1403. DOI:10.3390/ijms21041403.

5. Brady C., Ackerman P., Johnson M., McNamara J. Bordetella bronchiseptica in a pediatric Cystic Fibrosis center. J. Cyst. Fibros. 2014; 13 (1): 43–48. DOI:10.1016/j.jcf.2013.08.002.

6. Monti M., Diano D., Allegrini F., Delmonte A., Fausti V., Cravero P., et al. Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection. BMC Infect. Dis. 2017; 17 (1):644. DOI:10.1186/s12879-017-2736-7.

7. Coutts A. J., Dawson S., Binns S., Hart C. A., Gaskell C. J., Gaskell R. M. Studies on natural transmission of Bordetella bronchiseptica in cats. Vet. Microbiol. 1996; 48 (1–2): 19–27. DOI:10.1016/0378-1135(95)00128-x.

8. Dawson S., Jones D., McCracken C. M., Gaskell R. M., Hart C. A., Gaskell C. J. Bordetella bronchiseptica infection in cats following contact with infected dogs. Vet. Rec. 2000; 146 (2): 46–48. DOI:10.1136/vr.146.2.46.

9. Chen Y., Yang L., Sun E., Song J., Wu B. Characterisation of a newly detected bacteriophage infecting Bordetella bronchiseptica in swine. Arch. Virol. 2019; 164 (1): 33–40. DOI:10.1007/s00705-018-4034-0.

10. Park G. Y., Yu H. J., Son J. S., Park S. J., Cha H. J., Song K. S. Specific bacteriophage of Bordetella bronchiseptica regulates B. bronchiseptica-induced microRNA expression profiles to decrease inflammation in swine nasal turbinate cells. Genes Genomics. 2020; 42 (4): 441–447. DOI:10.1007/s13258-019-00906-7.

11. Dworkin M. S., Sullivan P. S., Buskin S. E., Harrington R. D., Olliffe J., MacArthur R. D., Lopez C. E. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 1999; 28 (5): 1095–1099. DOI:10.1086/514761.

12. Ner Z., Ross L. A., Horn M. V., Keens T. G., MacLaughlin E. F., Starnes V. A., Woo M. S. Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr. Transplant. 2003; 7 (5): 413–417. DOI:10.1034/j.13993046.2003.00074.x.

13. Powers H. R., Shah K. Bordetella bronchiseptica bloodstream infection in a renal transplant patient. Transpl. Infect. Dis. 2017; 19 (6). DOI:10.1111/tid.12774.

14. Rampelotto R. F., Hörner A., Hörner C., Righi R., Hörner R. Pneumonia caused by Bordetella bronchiseptica in two HIV-positive patients. Sao Paulo Med. J. 2016; 134 (3): 268–272. DOI:10.1590/1516-3180.2015.02492701.

15. Dewan K. K., Skarlupka A. L., Rivera I., Cuff L. E., Gestal M. C., Taylor-Mulneix D. L., et al. Development of macrolide resistance in Bordetella bronchiseptica is associated with the loss of virulence. J. Antimicrob. Chemother. 2018; 73 (10): 2797–2805. DOI:10.1093/jac/dky264.

16. Kadlec K., Schwarz S. Antimicrobial resistance in Bordetella bronchiseptica. Microbiol. Spectr. 2018; 6 (4). DOI:10.1128/microbiolspec.ARBA0024-2017.

17. Motovilova T. M., Kachalina T. S., Anikina T. A. Assessment of bacteriophages as etiotropic treatment for infectious and inflammatory processes on the pattern of chronic non-specific endometritis. The clinical view. Difficult Patient. 2013; 11 (8–9): 20–24. eLIBRARY ID: 20658728. (in Russ.)

18. Sadrtdinova G. R. Improvement of indication and identification scheme of Klebsiella oxytoca bacteria using phage biological product: author’s abstract of Candidate of Science (Biology) thesis. Ufa; 2017. 21 p. Available at: https://viewer.rsl.ru/ru/rsl01008710265?page=1&rotate=0&theme=white. (in Russ.)

19. Romanovа N. A., Feoktistovа N. A., Zolotukhin S. N., Vasilyev D. A., Aleshkin A. V. Comparative efficacy of isolation methods for phages of Bacillus megaterium. Vestnik veterinarii. 2013; 64 (1): 26–27. eLIBRARY ID: 18337641. (in Russ.)

20. Adams M. H. Bacteriophages. New York – London: Interscience Publishers; 1959. 592 p.

21. Goldfarb D. М. Bacteriophagy. Мoscow: Medgiz; 1961. 298 p. (in Russ.)

22. Medical microbiology guide. Book 1. General and sanitary microbiology. Ed. by A. S. Labinskaya, E. G. Volina. Мoscow: Binom; 2008. 1077 p. (in Russ.)

23. Ramesh N., Archana L., Madurantakam Royam M., Manohar P., Eniyan K. Effect of various bacteriological media on the plaque morphology of Staphylococcus and Vibrio phages. Access Microbiol. 2019; 1 (4):e000036. DOI:10.1099/acmi.0.000036.

24. Gorshkov I. G., Viktorov D. A., Vasilyev D. A. Isolation and study of biological properties of bacteriophages Aeromonas sobria. Vestnic of Ulyanovsk State Agricultural Academy. 2015; 3: 59–63. DOI:10.18286/1816-4501-20153-59-63. (in Russ.)

25. Aslanov B. I., Zueva L. P., Kaftyreva L. A., Boytsov A. G., Akimkin V. G., Dolgiy A. A., et al. Rational use of bacteriophages in medical and anti-epidemic practice: federal clinical (methodical) guidelines. Nizhny Novgorod: Remedium Privolzh’e; 2014. 54 р. (in Russ.)

26. Ryskaliyeva B. Zh., Bekkaliyeva A. K., Lyashenko E. A. Isolation and study of the biological properties of bacteriophages active against phytopathogenic bacteria Pectobacterium carotovorum. Ustoichivoe razvitie nauki i obrazovaniya. 2018; 10: 180–184. (in Russ.)

27. Semanina Е. N. Isolation and study of Bordetella bronchiseptica bacteriophage biological properties and development of a relevant biological product for indication and identification: author’s abstract of Candidate of Science (Biology) thesis. Saratov; 2012. 21 p. Available at: https://viewer.rsl.ru/ru/rsl01005012190?page=1&rotate=0&theme=white. (in Russ.)


Review

For citations:


Kochetova T.A., Yuskevich V.V., Sadykova G.T., Popova V.M. Isolation and study of biological properties of Bordetella bronchiseptica-specific bacteriophages. Veterinary Science Today. 2022;11(3):273-279. https://doi.org/10.29326/2304-196X-2022-11-3-273-279

Views: 489


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2304-196X (Print)
ISSN 2658-6959 (Online)